FDA Approves Gore Cardioform Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Apr 06, 2018

The FDA has approved an expanded indication of the Gore Cardioform Septal Occluder. | Read More



MR CLEAN Registry: Strong Link Between Stroke Outcomes, Time to Endovascular Treatment

Apr 03, 2018

The association between time to endovascular treatment and functional outcome in patients with acute ischemic stroke may be stronger than previously suggested. | Read More



FDA Approves Expanded Indication for Vascade Vascular Closure System

Apr 01, 2018

The FDA has approved an expanded indication of the Vascade Vascular Closure System, according to an announcement by Cardiva Medical. | Read More

varicose veins


Varicose Veins Linked With Increased Risk of DVT

Mar 07, 2018

Varicose veins are significantly associated with risk of developing deep vein thrombosis (DVT), researchers reported in JAMA. | Read More


OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

Feb 06, 2018

The authors followed the 12 month outcomes of 101 patients at 17 centers who participated in the OPTALYSE PE study in which the patients were randomized one of four cohorts. | Read More



Thrombectomy Effective Up to 16 Hours: DEFUSE 3 Trial

Jan 31, 2018

Current recommendations say that patients are eligible for thrombectomy within 6 hours of a stroke, but newly released results from the DEFUSE 3 trial suggest that the window of opportunity may extend up to 16 hours in certain patients. | Read More



Early TEVAR May Be Appropriate in Some Patients

Jan 19, 2018

Using certain clinical and anatomic features as a guide, it may be possible to predict whether patients with medically managed type B aortic dissection (TBAD) will benefit from early TEVAR. | Read More



FDA Approves Catheter for Use in PAD

Jan 10, 2018

The catheter is indicated for treatment of peripheral arterial disease (PAD), and it is designed to aid in true lumen passage of lesions, both above and below the knee, in the peripheral vasculature. | Read More

eluvia stent


MAJESTIC Trial Evaluates Long-Term Treatment Durability for Eluvia Stent

Dec 02, 2017

Building on the initial results of the MAJESTIC trial, researchers examined treatment durability at the 3-year mark. | Read More



Radiation During EVAR Damages Operators’ DNA

Nov 20, 2017

A study published in Circulation has shown for the first time that an acute DNA damage response occurs in operators performing fluoroscopically-guided interventions such as endovascular aortic repair (EVAR). | Read More